New Issue: Eksportfinans prices $708,000 of 35.5% reverse convertibles linked to Savient via Natixis

By Laura Lutz

Des Moines, Oct. 16 - Eksportfinans ASA priced a $708,000 issue of 35.5% reverse convertible notes due April 17, 2008 linked to the common stock of Savient Pharmaceuticals, Inc., according to a 424B3 filing with the Securities and Exchange Commission.

Natixis Securities North America Inc. is the underwriter.

Interest will be payable monthly.

At maturity, investors will receive par unless Savient stock falls below the knock-in price, 50% of the initial price of $15.27, during the life of the notes and finishes below the initial price. Otherwise, the payout will be in Savient stock, with the number of share equal to $1,000 divided by the initial share price.

Issuer:	Eksportfinans ASA
Issue:	Reverse convertible notes
Amount:	$708,000
Underlying stock:	Savient Pharmaceuticals, Inc. (Symbol: SVNT)
Maturity:	April 17, 2008
Coupon:	35.5%, payable monthly
Price:	Par
Payout at maturity:	Par in cash if Savient stock stays at or above the knock-in price of $7.635 or finishes at or above the initial price; otherwise, shares of Savient stock equal to $1,000 divided by the initial price
Initial price:	$15.27
Knock-in price:	$7.635, 50% of $15.27
Pricing date:	Oct. 12
Settlement date:	Oct. 17
Agent:	Natixis Securities North America Inc.
Fees:	2.5%

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.